PTC Therapeutics
A science-led, patient-centered biopharmaceutical company focused on discovering, developing and commercializing medicine for patients with rare disease.
Launch date
Employees
Market cap
€2.3b
Enterprise valuation
€1.7b (Public information from Sep 2024)
Share price
$35.48 PTCT
South Plainfield New Jersey (HQ)
Authorizing premium user...